Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Moderna, Inc.(MRNA) | 9,666,038 | 9,666,038 | 0 | $961.29M | $1.03B | 67.56% | +$68.73M |
| Sana Biotechnology, Inc.(SANA) | 25,001,856 | 25,001,856 | 0 | $102.01M | $250.02M | 16.40% | +$148.01M |
| Omega Therapeutics Inc | 29,225,579 | 29,225,579 | 0 | $87.97M | $106.67M | 7.00% | +$18.70M |
| Foghorn Therapeutics Inc.(FHTX) | 12,674,120 | 12,674,120 | 0 | $81.75M | $85.04M | 5.58% | +$3.30M |
| Denali Therapeutics Inc.(DNLI) | 2,319,968 | 1,364,516 | -955,452 | $49.79M | $28.00M | 1.84% | -$21.79M |
| Seres Therapeutics, Inc.(MCRB) | 23,117,045 | 23,117,045 | 0 | $32.43M | $17.89M | 1.17% | -$14.54M |
| Syros Pharmaceuticals Inc | 1,293,848 | 1,293,849 | +1 | $10.08M | $6.92M | 0.45% | -$3.16M |